Please browse the below free and open access resources related to pharmacovigilance 

Pharmacovigilance in Children and Adolescents

EMA Guideline on good pharmacovigilance practices (GVP) Product- or Population-Specific Considerations IV: Paediatric population

 

Pharmacovigilance in Pregnancy 

Pharmacovigilance Communications

 

Publications

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety (Nov 2021)

COVID-19 Vaccination Outcomes Among Breastfeeding Women and Their Children – a Pharmacovigilance Survey Research (Oct 2021)

 

c4c: Paediatric pharmacovigilance: Methodological considerations in research and development of medicines for children – A c4c expert group white paper (Oct 2021)

Adverse drug reactions in children and young people (May 2021)

Pharmacovigilance in Pediatric Population (Feb 2019)

Pediatric Pharmacovigilance: Current Practice and Future Perspectives (Oct 2018)

Pharmacovigilance for Children’s Sake (Jan 2014)

Children and ADRs (Adverse Drug Reactions) (Jan 2010)

The importance of pharmacovigilance in the pediatric population (May 2009)